Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/1999
08/17/1999US5939466 Contact lenses; drug delivery
08/17/1999US5939453 PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
08/17/1999US5939427 Lotion with 17-allyl-1,4-dihydroxy-12-(2-(4-hydroxy-3-methoxy cyclohexyl)-1-methylvinyl)-23,25-dimethoxy-13,19,21,27-tetrame thyl-11,28-dioxa-4-azatricyclo(22.3.1.0(4,9))octacos-18-ene-1, 3,10,16-tetraone or salt as antiinflammatory agent
08/17/1999US5939401 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
08/17/1999US5939394 Treatment of allergies and autoimmune diseases, antioxidants and magnesium gluconate
08/17/1999US5939390 Pharmaceutical composition
08/17/1999US5939380 Bioerosion preparation for implants with sustained action of polypeptides with lipid powders
08/17/1999US5939100 Diminishing the desire of a subject to use tobacco by administering thepowdery pharmaceutical microspheres
08/17/1999US5939095 At least one parasympathomimetically active substance and at least one parasympatholytically active substance
08/17/1999US5939094 Dosage form
08/17/1999US5939090 Gel formulations for topical drug delivery
08/17/1999US5939084 Containing glycol to dissolve melatonin; prevention of oxidative stress
08/17/1999US5939083 Nongreasy/nonsticky fatty cosmetic/dermatological compositions
08/17/1999US5939070 Hybrid botulinal neurotoxins
08/17/1999US5939047 Local delivery of chemotherapeutic agents for treatment of periodontal disease
08/17/1999CA2152262C Process to prepare pharmaceutical compositions containing vecuronium bromide
08/17/1999CA2105180C Compositions containing sumatriptan
08/17/1999CA2098738C Controlled release oxycodone compositions
08/17/1999CA2076648C Composition for inducing humoral anergy to an immunogen
08/17/1999CA2042722C Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
08/12/1999WO1999040214A2 Nucleic acid delivery vehicles
08/12/1999WO1999040200A1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
08/12/1999WO1999040153A1 Acid-stable and cationic-compatible cellulose compositions and methods of preparation
08/12/1999WO1999040113A2 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
08/12/1999WO1999040112A1 Neuroprotective peptides and uses thereof
08/12/1999WO1999039741A2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy
08/12/1999WO1999039740A2 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
08/12/1999WO1999039739A1 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media
08/12/1999WO1999039738A1 Targeted delivery of biologically active media
08/12/1999WO1999039732A1 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections
08/12/1999WO1999039731A1 Copolymer compositions for oral delivery
08/12/1999WO1999039730A1 Oral preparations containing peptides promoting the secretion of growth hormone
08/12/1999WO1999039717A1 Pharmaceutical composition for nasal administration of thiocolchicoside
08/12/1999WO1999039713A1 Piroxicam-containing hydroalcoholic gel composition
08/12/1999WO1999039709A1 Liquid pharmaceutical formulation containing zotepine
08/12/1999WO1999039708A1 Tablets to be crunched or sucked, comprising iron as active principle
08/12/1999WO1999039707A1 Metal-thiols as immunomodulating agents
08/12/1999WO1999039700A1 Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process
08/12/1999WO1999039699A1 Treatment of chronic inflammatory disorders of the gastrointestinal tract
08/12/1999WO1999039696A1 Propofol composition containing sulfite
08/12/1999WO1999039695A1 Emulsion for transdermal administration of an active principle
08/12/1999WO1999039694A2 Compositions containing organic compounds
08/12/1999WO1999039692A2 Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization
08/12/1999WO1999039691A2 Pharmaceutical compositions
08/12/1999WO1999039580A1 Stable liquid mineral ascorbate compositions and methods of manufacture and use
08/12/1999WO1999029280A3 Anti-picornaviral ligands via a combinatorial computational and synthetic approach
08/12/1999WO1999027916A3 Method for producing solid dosing forms
08/12/1999WO1999026606A3 SUSTAINED RELEASE FORMULATIONS COMPRISING α-GLUCOSIDASE-INHIBITORS
08/12/1999WO1999024471A9 Opiate, cannabinoid, and estrogen receptors
08/12/1999WO1999024063A9 Compositions providing for increased igf-i solubility
08/12/1999WO1999022761A9 Conjugate heat shock protein-binding peptides
08/12/1999WO1999013864A3 Solid solution beadlet
08/12/1999WO1999008657A3 Self-binding shearform compositions
08/12/1999WO1999006032A3 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
08/12/1999WO1999004822A3 New salts with beneficial organoleptic properties
08/12/1999WO1999004820A3 Cytolysis of target cells by superantigen conjugates inducing t-cell activation
08/12/1999WO1999002132A3 Use of submicron oil-in-water emulsions with dna vaccines
08/12/1999WO1999002130A3 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin
08/12/1999WO1998057662A3 Therapeutic systems
08/12/1999DE19805433A1 Verwendung von Detergensgemischen als Lösungsvermittler The use of detergent mixtures as solubilizers
08/12/1999DE19803453A1 Vakzine Vaccine
08/12/1999CA2320490A1 Neuroprotective peptides and uses thereof
08/12/1999CA2320475A1 Liquid pharmaceutical formulation containing zotepine
08/12/1999CA2320470A1 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media
08/12/1999CA2319565A1 Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process
08/12/1999CA2319468A1 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
08/12/1999CA2319463A1 Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization
08/12/1999CA2319356A1 Composition and methods for treatment of hiv infection
08/12/1999CA2319140A1 Acid-stable and cationic-compatible cellulose compositions and methods of preparation
08/12/1999CA2319011A1 Tablets to be crunched or sucked, comprising iron as active principle
08/12/1999CA2318981A1 Nucleic acid delivery vehicles
08/11/1999EP0934921A1 Waxes based on native raw material
08/11/1999EP0934744A1 Nitroglycerin preparation for treatment of erectile dysfunction
08/11/1999EP0934742A2 High glycerin containing anti-microbial cleansers
08/11/1999EP0934741A1 Hair growth stimulants
08/11/1999EP0934593A1 Electrically conductive adhesive hydrogels
08/11/1999EP0934342A1 Composition containing chitosan
08/11/1999EP0934341A1 Inclusion complexes of beta-2-andrenergics for oral mucosal delivery
08/11/1999EP0934082A2 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates
08/11/1999EP0934081A2 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
08/11/1999EP0934080A2 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
08/11/1999EP0934079A1 Pharmaceutical composition containing lornoxicam and a disodic salt of edta
08/11/1999EP0934078A2 Permeation enhancers for transdermal drug delivery compositions, devices, and methods
08/11/1999EP0934077A2 Polyanionic polymers as adjuvants for mucosal immunization
08/11/1999EP0934059A1 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules
08/11/1999EP0934058A2 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
08/11/1999EP0827514B1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
08/11/1999EP0788347B1 Stable reverse and multiple fluorocarbon emulsions
08/11/1999EP0671904B1 Antibiotic formulation and use for bacterial infections
08/11/1999EP0636023B1 Aminoguanidine spray drying process
08/11/1999EP0580778B1 Convertible microemulsion formulations
08/11/1999CN1225631A Bioconjugates of manganese or iron complexes of nitrogen-contg. macrocyclic ligands effective as catalysis for dismutating superoxide
08/11/1999CN1225591A Membrane incorporation of texaphyrins
08/11/1999CN1225587A Compositions comprising an HIV protease inhibitor such as VX 478 and a water soluble vitamin E compound such as vitamin E-TPGS
08/11/1999CN1225257A Non-transfusion cosmetics contg. non-film-forming polymer particles existing in partially non-volatile liquid aoliphatic phase
08/11/1999CN1044559C Injection for curing leukemia, liver cancer and lymphoma
08/10/1999US5936092 Fatty acid conjugate containing a disulfide linkage; increased absorption of compounds
08/10/1999US5936035 Comprising fibrillar collagen, a fiber disassembly agent to make nonfibrillar collagen and an activated polymer, e.g. polyoxyethylene glycol to form a covalently bonded collagen-polymer conjugate; surgical adhesions; eye implants
08/10/1999US5936019 Polyurethane-based thickener compositions and their use for thickening aqueous compositions
08/10/1999US5936002 Cosmetically/pharmaceutically/hygienically-active supple doughs comprising heat-sensitive compounds
1 ... 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 ... 1712